Agilon Health Inc Stock Price, News & Analysis

Agilon Health, Inc. (NYSE: AGL) reported a 52% revenue increase to $695 million for Q3 2022, compared to $459 million in Q3 2021. Total membership grew 45% to 266,600 Medicare Advantage members, with total members on the platform reaching 356,000. The medical margin surged 74% to $76 million, representing 10.9% of revenue. Adjusted EBITDA improved to $15 million for the first nine months. Despite a net loss of $31 million for Q3, the outlook for FY 2022 reflects continued membership and revenue growth.

agilon health, inc. (NYSE: AGL) will release its Q3 2022 financial results on November 3, 2022, after the market closes. A conference call is scheduled for 5:00 PM ET on the same day, accessible by phone or through a webcast on the company’s Investor Relations site. The event aims to discuss the financial results and provide insights to investors. agilon health focuses on empowering physicians and transitioning to a value-based Total Care Model for senior patients, serving 17 communities.

agilon health, inc. (NYSE: AGL) announced its participation in two key investor conferences. The first is the Wells Fargo Healthcare Conference on September 8 at 10:25 AM ET, followed by the Morgan Stanley 20th Annual Global Healthcare Conference on September 14 at 3:30 PM ET. Investors can access live webcasts of these events through the agilon health investor relations website. The company focuses on empowering physicians to enhance healthcare services in communities, transitioning to a value-based Total Care Model for senior patients.

agilon health announces the retirement of Michael Smith from its board of directors after over five years. Jeff Schwaneke, previously Executive VP at Centene Corporation, will join as an independent board member. Schwaneke brings extensive experience including overseeing a $35 billion pharmacy business and a significant growth in revenues at Centene, from $20 billion to $125 billion. The company views this transition as crucial for its growth during an evolving healthcare landscape.

Agilon Health (NYSE: AGL) reported significant financial growth for Q2 2022, with total revenue reaching $670 million, a 34% increase from Q2 2021. Year-to-date, revenue surged 45% to $1.32 billion. Medicare Advantage membership increased by 44%, totaling 261,200 members. The company's medical margin rose 49% to $82 million, reflecting a margin of 12.2% of revenue. Despite a net loss of $21 million, a notable improvement from a $299 million loss last year, Agilon reported an adjusted EBITDA of $7 million, up from negative $2 million.

agilon health, inc. (NYSE: AGL) will release its financial results for Q2 2022 on August 4, 2022, after market close. A conference call is scheduled for 5:00 PM ET to discuss these results, accessible via (844) 200-6205 for U.S. participants and +1 (646) 904-5544 for international callers, using participant code 043762. The call will also be available as a webcast on agilon's Investor Relations website. agilon health aims to support physician groups transitioning to a value-based care model, creating healthier communities.

Agilon Health has appointed Denise Zamore as its first Chief Legal Officer and Secretary, effective August 1, 2022. She brings over 15 years of legal experience in the healthcare sector, previously serving at Optum and United Healthcare. Zamore will be an integral part of the executive leadership team, reporting to CEO Steve Sell. This new role aims to bolster Agilon's legal framework as it undergoes rapid organizational growth.

agilon health, inc. (NYSE: AGL) will present at the William Blair 42nd Annual Growth Stock Conference on June 8 at 9:40 AM Eastern Time. Investors can access the presentation via a webcast available on agilon's investor relations website. The company focuses on empowering physicians to improve health outcomes through a value-based care model, facilitating independence and enhancing community health through its technology and support services.